Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Upstream Bio (UPB) Share-based Compensation (2023 - 2025)

Upstream Bio (UPB) has 3 years of Share-based Compensation data on record, last reported at $2.6 million in Q3 2025.

  • For Q3 2025, Share-based Compensation rose 39.24% year-over-year to $2.6 million; the TTM value through Sep 2025 reached $9.9 million, up 115.43%, while the annual FY2024 figure was $6.0 million, 75.2% up from the prior year.
  • Share-based Compensation reached $2.6 million in Q3 2025 per UPB's latest filing, roughly flat from $2.6 million in the prior quarter.
  • Across five years, Share-based Compensation topped out at $2.6 million in Q1 2025 and bottomed at $643000.0 in Q1 2024.
  • Average Share-based Compensation over 3 years is $1.8 million, with a median of $2.0 million recorded in 2024.
  • The widest YoY moves for Share-based Compensation: up 309.8% in 2025, down 39.24% in 2025.
  • A 3-year view of Share-based Compensation shows it stood at $683000.0 in 2023, then skyrocketed by 205.42% to $2.1 million in 2024, then grew by 24.35% to $2.6 million in 2025.
  • Per Business Quant database, its latest 3 readings for Share-based Compensation were $2.6 million in Q3 2025, $2.6 million in Q2 2025, and $2.6 million in Q1 2025.